Top Institutions in Rare Genetic and Hematologic Disorders
Institutions were ranked based on their known leadership in rare hematologic and genetic disorders, expertise in plasminogen deficiency research, clinical trial involvement with novel therapies such as RYPLAZIM, and multidisciplinary management of rare ocular and systemic diseases.
-
#1
National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI)
Bethesda, MD
The NIH/NHLBI leads in rare hematologic disorder research, including plasminogen deficiency, with extensive clinical trial infrastructure and translational research programs focused on novel therapies like RYPLAZIM.
-
#2
Mayo Clinic
Rochester, MN
Mayo Clinic has multidisciplinary expertise in rare hematologic and ocular diseases, offering comprehensive diagnostic and therapeutic services for PLGD-1 and ligneous conjunctivitis with active involvement in rare disease registries.
-
#3
Cincinnati Children's Hospital Medical Center
Cincinnati, OH
Known for pediatric expertise in rare genetic and hematologic disorders, Cincinnati Children's has contributed to understanding PLGD-1 manifestations in children and has participated in clinical trials for novel treatments.
-
#4
Massachusetts General Hospital (MGH)
Boston, MA
MGH combines strong hematology and ophthalmology programs with translational research in rare coagulation and fibrinolytic disorders, contributing to advancements in diagnosis and management of PLGD-1.